Sydney, Australia, 3 August 2023: Imugene Limited (ASX:IMU), a clinical stage immunooncology company, is pleased to announce that its CF33 Oncolytic Virus technology will
be featured at the renowned Annual Meeting for the Society for Immunotherapy of Cancer
(SITC), to be held in San Diego, USA on 1-5 November 2023
IMUGENE CHART. TA only, page-25920
-
- There are more pages in this discussion • 8,063 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |